Eva Schernhammer, D.P.H., M.D.
Adjunct Professor of Epidemiology, Harvard T.H. Chan School of Public Health
Lecturer on Medicine, Part-time, Brigham and Women's Hospital
Harvard Titles
Adjunct Professor Epidemiology, Harvard T.H. Chan School of Public Health
Lecturer on Medicine, Part-time
Other Affiliations
Channing Division of Network Medicine, Brigham and Women's Hospital
Address
Channing Laboratory
181 Longwood Avenue, 4th Floor, Room 444
Boston, MA 02115
Publications View
Intra-individual dose escalation with carboplatin/mitomycin C in advanced breast cancer
Authors: Kienzer H, Baur M, Faezeny M, DeSantis M, Poehnl R, Schernhammer E, Postner G, Kraus R, Point J, Dittrich C
Ann Oncol (Pro ESMO, Athens, Greece)
Ann Oncol (Pro ESMO, Athens, Greece)
Pharmacokinetic interaction between 4'-epidoxorubicin and the multidrug resistance reverting agent quinine.
Authors: Czejka M, Bandak S, Simon D, Schüller J, Weiss C, Schernhammer E.
Z Naturforsch C J Biosci
View full abstract on Pubmed
Z Naturforsch C J Biosci
View full abstract on Pubmed
[Drug interactions between interferon alpha 2b and 5-fluorouracil during continuous intravenous 5FU infusion].
Pharmacokinetic drug interaction between epirubicin and interferon-alpha-2b in serum and red blood cells.
Authors: Bandak S, Czejka M, Schüller J, Schernhammer E.
Arzneimittelforschung
View full abstract on Pubmed
Arzneimittelforschung
View full abstract on Pubmed
Dexverapamil to overcome epirubicin resistance in advanced breast cancer.
Authors: Thürlimann B, Kröger N, Greiner J, Mross K, Schüller J, Schernhammer E, Schumacher K, Gastl G, Hartlapp J, Kupper H, et al.
J Cancer Res Clin Oncol
View full abstract on Pubmed
J Cancer Res Clin Oncol
View full abstract on Pubmed
Pharmacokinetic interaction between 4’-epidoxorubicin and the multidrug resistance reverting agent quinine
Authors: Czejka M, Bandak S, Simon D, Schueller J, Weiss C, Schernhammer E
Z Naturforschung
Z Naturforschung
Epirubicin pharmacokinetics, influence of interferon alfa 2b in advanced cancer patients
Authors: Schueller J, Czejka M, Bandak S, Wirth M, Schernhammer E, Schernthaner G
Pro ASCO, Dallas, TX
Pro ASCO, Dallas, TX
Light and Dark Activity and Rest in Dayshift and Nightshift Nurses
Authors: Rea M, Biermann A, Figueiro M, Zhou Y, Schernhammer E
Pro Society for Light Treatment and Biological Rhythms (SLTBR) 19th Annual Meeting, Copenhagen, Denmark, 2007
Pro Society for Light Treatment and Biological Rhythms (SLTBR) 19th Annual Meeting, Copenhagen, Denmark, 2007
Therapie von Karzinomschmerzen
Authors: Schueller J, Schernhammer E, Weiss C, Fogl U
3
3
IARC monographs on the evaluation of carcinogenic risks to humans
Authors: IARC, Monograph Working Group [Member]
Volume 98
Volume 98